article Open AccessTop 1% cited
Cancer immunotherapy: moving beyond current vaccines
Nature Medicine · 2004 · Vol. 10(9) · pp. 909–915
Steven A. Rosenberg✉(Center for Cancer Research)James C. Yang(National Cancer Institute)Nicholas P. Restifo(Center for Cancer Research)
Immunotherapy and Immune Responsesvaccines and immunoinformatics approachesCancer Immunotherapy and BiomarkersMedicineClinical trialCancer vaccineCancerCancer immunotherapyImmunotherapyCancer immunologyOptimismSurrogate endpointOncology
MeSH terms
AdolescentAdultAgedChildClinical Trials as TopicFemaleHumansImmunotherapyMaleMiddle AgedNeoplasm MetastasisNeoplasmsT-LymphocytesTreatment OutcomeModels, Immunological
Citations
2,953
FWCI
53.53
field-weighted impact
References
75
Percentile
100%
vs. same field & year
Citations per year
Cited by
Targeting Treg cells in cancer immunotherapy
European Journal of Immunology · 2019 · 481 citations
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Clinical Cancer Research · 2016 · 1,045 citations
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Science Translational Medicine · 2016 · 2,413 citations
IL-2: The First Effective Immunotherapy for Human Cancer
The Journal of Immunology · 2014 · 1,253 citations
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Clinical Cancer Research · 2011 · 2,095 citations
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Clinical Cancer Research · 2014 · 781 citations
Vaccine Adjuvants: Putting Innate Immunity to Work
Immunity · 2010 · 1,888 citations
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
Breast Cancer Research and Treatment · 2014 · 577 citations
References
Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
Nature Immunology · 2010 · 5,839 citations
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nature Medicine · 1998 · 2,862 citations
Toll-Like Receptors
Annual Review of Immunology · 2003 · 6,131 citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
JNCI Journal of the National Cancer Institute · 2000 · 15,689 citations
Reporting results of cancer treatment
Cancer · 1981 · 7,848 citations
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
The Journal of Immunology · 1995 · 5,432 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.